Cabot-Wellington’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,398
Closed -$228K 6
2022
Q3
$228K Sell
1,398
-495
-26% -$83.8K 0.15% 6
2022
Q2
$336K Sell
1,893
-1,488
-44% -$265K 0.21% 7
2022
Q1
$519K Hold
3,381
0.26% 8
2021
Q4
$578K Hold
3,381
0.27% 9
2021
Q3
$546K Sell
3,381
-69
-2% -$11.8K 0.25% 9
2021
Q2
$568K Hold
3,450
0.26% 9
2021
Q1
$567K Sell
3,450
-47
-1% -$7.61K 0.27% 9
2020
Q4
$550K Sell
3,497
-31
-0.9% -$4.58K 0.28% 9
2020
Q3
$525K Sell
3,528
-27
-0.8% -$4K 0.33% 5
2020
Q2
$500K Buy
3,555
+105
+3% +$15.3K 0.34% 5
2020
Q1
$471K Hold
3,450
0.38% 5
2019
Q4
$501K Hold
3,450
0.31% 5
2019
Q3
$480K Hold
3,450
0.33% 5
2019
Q2
$480K Hold
3,450
0.33% 5
2019
Q1
$482K Hold
3,450
0.33% 5
2018
Q4
$445K Hold
3,450
0.3% 5
2018
Q3
$477K Hold
3,450
0.3% 5
2018
Q2
$418K Hold
3,450
0.29% 6
2018
Q1
$442K Hold
3,450
0.33% 5
2017
Q4
$482K Hold
3,450
0.29% 8
2017
Q3
$448K Hold
3,450
0.26% 10
2017
Q2
$456K Hold
3,450
0.26% 11
2017
Q1
$438K Sell
3,450
-1,200
-26% -$143K 0.26% 12
2016
Q4
$535K Hold
4,650
0.39% 12
2016
Q3
$549K Hold
4,650
0.44% 12
2016
Q2
$575K Sell
4,650
-300
-6% -$34.1K 0.5% 12
2016
Q1
$536K Hold
4,950
0.4% 16
2015
Q4
$508K Hold
4,950
0.35% 18
2015
Q3
$462K Hold
4,950
0.28% 22
2015
Q2
$482K Hold
4,950
0.24% 22
2015
Q1
$498K Sell
4,950
-865
-15% -$88K 0.21% 30
2014
Q4
$608K Hold
5,815
0.23% 31
2014
Q3
$620K Hold
5,815
0.23% 29
2014
Q2
$608K Sell
5,815
-50
-0.9% -$5.05K 0.22% 30
2014
Q1
$576K Hold
5,865
0.22% 30
2013
Q4
$537K Hold
5,865
0.2% 30
2013
Q3
$508K Buy
5,865
+125
+2% +$11.2K 0.2% 30
2013
Q2
$493K Buy
+5,740
New +$487K 0.21% 31

Other funds holding JNJ

Cabot-Wellington's JNJ Position: Q4 2022 in Review

Cabot-Wellington sold out of Johnson & Johnson (JNJ) in Q4 2022, closing a stake of 1,398 shares — an estimated $228K sold.

Cabot-Wellington first reported a position in JNJ in Q2 2013 and held it in 38 quarters. The position peaked at $620K in Q3 2014. 3,789 funds tracked by Wall St. Rank hold JNJ as of Q4 2022.

  • Cabot-Wellington reported no remaining Johnson & Johnson position as of Q4 2022 after selling out during the quarter.
  • Cabot-Wellington sold 1,398 Johnson & Johnson shares in Q4 2022, an estimated $228K.
  • Cabot-Wellington first reported a position in Johnson & Johnson in Q2 2013 and held it in 38 quarters.
  • Cabot-Wellington's Johnson & Johnson position peaked at $620K in Q3 2014.
  • 3,789 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2022.

Based on Cabot-Wellington's 13F filing for Q4 2022, filed 21 Mar 2023.